MODIFIED STAGE-I (T1NOM0, T2NOM0), NONSMALL CELL LUNG-CANCER - TREATMENT RESULTS, RECURRENCE PATTERNS, AND ADJUVANT IMMUNOTHERAPY

被引：0
|
作者：
LITTLE, AG
DEMEESTER, TR
FERGUSON, MK
SKINNER, DB
HOFFMAN, PC
SKOSEY, C
BLOUGH, RR
GOLOMB, HM
机构：
[1] UNIV CHICAGO,CTR MED,DEPT MED,CHICAGO,IL 60637
[2] UNIV CHICAGO,CTR MED,BIOMED COMPUTAT FACILITIES,CHICAGO,IL 60637
来源：
SURGERY | 1986年 / 100卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：621 / 628
页数：8
相关论文
共 50 条
  • [21] Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)
    Zimmermann, Frank B.
    Geinitz, Hans
    Schill, Sabine
    Thamm, Reinhard
    Nieder, Carsten
    Schratzenstaller, Ulrich
    Molls, Michael
    ACTA ONCOLOGICA, 2006, 45 (07) : 796 - 801
  • [22] COMPLETE RESECTION AND COMBINED CHEMOTHERAPY - TREATMENT OF CHOICE FOR T1T2N0M0 SMALL CELL-CANCER OF THE LUNG (SCCL)
    ROCMANS, P
    VANHOUTTE, P
    DEFRANCQUEN, P
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 37 - 38
  • [23] Surgical results in T2N0M0 nonsmall cell lung cancer patients with large tumors 5 cm or greater in diameter: What regulates outcome?
    Ohta, Yasuhiko
    Waseda, Ryuichi
    Minato, Hiroshi
    Endo, Naoki
    Shimizu, Yosuke
    Matsumoto, Isao
    Watanabe, Go
    ANNALS OF THORACIC SURGERY, 2006, 82 (04): : 1180 - 1184
  • [24] Lobectomy versus sublobar resection for stage I (T1-T2aN0M0) small cell lung cancer: A SEER population-based propensity score matching analysis
    Zhou, Ning
    Yang, Lingqi
    Zhang, Bo
    Zhu, Shuai
    Huo, Huandong
    He, Jinling
    Zu, Lingling
    Song, Zuoqing
    Xu, Song
    CANCER MEDICINE, 2023, 12 (07): : 7923 - 7931
  • [25] Role of adjuvant therapy in T1-2N0 resected non-small cell lung cancer
    Woodard, Gavitt A.
    Li, Andrew
    Boffa, Daniel J.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (05): : 1685 - 1692
  • [26] Expression and association of HER2 with prognosis in early-stage (T1-T2N0M0) non-small cell lung cancer
    Xia, Qing
    Zhu, Zhihua
    Wang, Jian
    Situ, Dongrong
    Zhou, Ningning
    Jang, Wenqi
    TUMOR BIOLOGY, 2012, 33 (05) : 1719 - 1725
  • [27] Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
    Seong Yong Park
    Jin Gu Lee
    Jieun Kim
    Go Eun Byun
    Mi Kyung Bae
    Chang Young Lee
    Dae Joon Kim
    Kyung Young Chung
    Journal of Cardiothoracic Surgery, 8
  • [28] Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
    Park, Seong Yong
    Lee, Jin Gu
    Kim, Jieun
    Byun, Go Eun
    Bae, Mi Kyung
    Lee, Chang Young
    Kim, Dae Joon
    Chung, Kyung Young
    JOURNAL OF CARDIOTHORACIC SURGERY, 2013, 8
  • [29] Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer
    Landreneau, RJ
    Sugarbaker, DJ
    Mack, MJ
    Hazelrigg, SR
    Luketich, JD
    Fetterman, L
    Liptay, MJ
    Bartley, S
    Boley, TM
    Keenan, RJ
    Ferson, PF
    Weyant, RJ
    Naunheim, KS
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (04): : 691 - 700
  • [30] Stereotactic Body Radiation and Adjuvant Chemotherapy Versus Surgery and Adjuvant Chemotherapy For T1-2N0 Small Cell Lung Cancer
    Johnson, Skyler B.
    Stahl, John M.
    Miccio, Joseph A.
    Kann, Benjamin H.
    Kelly, Jacqueline R.
    Decker, Roy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E3 - E3
12345